Search For "resectable melanoma"
Study reveals how immunotherapy treatment produces exceptional response i
Updated : 2 years, 11 months ago IST
A startling 89 per cent of desmoplastic melanoma patients in a nationwide clinical study responded to immunotherapy (pembrolizumab) alone, indicating that many patients could avoid the potential side effects of combination therapies and achieve disease control with this course of treatment.
Read More